Innogenetics Court Likens Royalty Award To License

Law360, New York (March 7, 2008, 12:00 AM EST) -- The U.S. Court of Appeals for the Federal Circuit recently addressed a multitude of issues and vacated an injunction against Abbott Laboratories while upholding in part a ruling that Abbott infringed an Innogenetics patent for detecting and classifying hepatitis C virus genotypes. Innogenetics, N.V. v. Abbott Laboratories, Case Nos. 07-1145, -1061 (Fed. Cir., Jan. 17, 2008) (Moore J.).

Innogenetics’ patent claims a method of genotyping hepatitis C virus (HCV) based on distinct genetic sequences that can be found in the 5 prime untranslated region (5' UTR)...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.